INTELLECTUAL PROPERTYAt the heart of Neuralstem’s therapeutic cell development programs is the is ability to isolate and grow human neural stem cells from diverse regions of the developing human brain and spinal cord.
This technology is supported by our portfolio of issued and pending patents. The Company has a very pro active plan for obtaining and protecting it’s stem cell Intellectual Property, not just in the United States, but world wide. In addition to it’s stem cell intellectual property, the company has been active in licensing in important intellectual property rights for newly developed devices and equipment that will be required to optimize delivery of it’s stem cell therapeutics through surgical transplantation into the brain and spinal cord. Patents Issued Number | Country | Filing Date | Issue Date | Expiration Date | Title | | 5,753,506 | US | 09/25/96 | 05/19/98 | 09/25/2016 | Isolation, Propagation, and Directed Differentiation of Stem Cell from Embryonic and Adult Central Nervous System of Mammals | | 6,040,180 | US | 05/07/97 | 03/21/00 | 09/25/2016 | In Vitro Generation of Differentiated Neurons from Cultures of Mammalian Multi-potential CNS Stem Cell | | 6,284,539 | US | 10/09/98 | 09/04/01 | 10/9/2018 | Method for Generating Dopaminergic Cells Derived from Neural Precursors | | 755849 | Australia | 09/22/99 | 04/03/03 | 09/20/2019 | Stable Neural Stem Cell Lines |
| 